Mengzhong Liu

4.0k total citations · 1 hit paper
77 papers, 1.9k citations indexed

About

Mengzhong Liu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mengzhong Liu has authored 77 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Surgery, 37 papers in Pulmonary and Respiratory Medicine and 29 papers in Oncology. Recurrent topics in Mengzhong Liu's work include Esophageal Cancer Research and Treatment (33 papers), Gastric Cancer Management and Outcomes (19 papers) and Esophageal and GI Pathology (15 papers). Mengzhong Liu is often cited by papers focused on Esophageal Cancer Research and Treatment (33 papers), Gastric Cancer Management and Outcomes (19 papers) and Esophageal and GI Pathology (15 papers). Mengzhong Liu collaborates with scholars based in China, United States and Sweden. Mengzhong Liu's co-authors include Ying Sun, Aihua Lin, Jun Ma, Lizhi Liu, Lei Chen, Wei Luo, Wen‐Fei Li, Yuanyuan Chen, Mian Xi and Shiliang Liu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer.

In The Last Decade

Mengzhong Liu

73 papers receiving 1.9k citations

Hit Papers

How Does Intensity-Modulated Radiotherapy Versus Conventi... 2010 2026 2015 2020 2010 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. How Does Intensity-Modulated Radiotherapy Versus Conventional Two-Dimensional Radiotherapy Influence the Treatment Results in Nasopharyngeal Carcinoma Patients?
    2010 530 citations Mengzhong Liu, Jun Ma et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengzhong Liu China 22 896 803 749 674 431 77 1.9k
Jeremy Setton United States 20 431 0.5× 424 0.5× 368 0.5× 646 1.0× 259 0.6× 51 1.3k
Shixiu Wu China 23 408 0.5× 545 0.7× 496 0.7× 212 0.3× 624 1.4× 71 1.6k
K.K. Ang United States 15 390 0.4× 508 0.6× 580 0.8× 340 0.5× 302 0.7× 59 1.4k
Peter M. L. Teo China 14 871 1.0× 490 0.6× 788 1.1× 1.2k 1.8× 181 0.4× 25 1.7k
Tyler P. Robin United States 17 272 0.3× 405 0.5× 608 0.8× 169 0.3× 330 0.8× 55 1.3k
Xiaoyu Tu China 13 223 0.2× 567 0.7× 688 0.9× 386 0.6× 520 1.2× 39 1.5k
Mei‐Kim Ang Singapore 19 319 0.4× 473 0.6× 658 0.9× 411 0.6× 372 0.9× 64 1.3k
Henry Sze China 19 621 0.7× 533 0.7× 560 0.7× 1.0k 1.5× 218 0.5× 30 1.5k
Rou Jiang China 17 398 0.4× 288 0.4× 480 0.6× 541 0.8× 168 0.4× 22 987
Yi‐Jun Hua China 14 404 0.5× 344 0.4× 383 0.5× 516 0.8× 214 0.5× 34 971

Countries citing papers authored by Mengzhong Liu

Since Specialization
Citations

This map shows the geographic impact of Mengzhong Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengzhong Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengzhong Liu more than expected).

Fields of papers citing papers by Mengzhong Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengzhong Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengzhong Liu. The network helps show where Mengzhong Liu may publish in the future.

Co-authorship network of co-authors of Mengzhong Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengzhong Liu. A scholar is included among the top collaborators of Mengzhong Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengzhong Liu. Mengzhong Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhong, Jian, Rui Chen, Xiuying Xie, et al.. (2024). The patterns and risk factors for relapse in oesophageal squamous cell cancers that achieve pathological complete response to neoadjuvant chemoradiotherapy. European Journal of Cardio-Thoracic Surgery. 65(6). 4 indexed citations
2.
Fu, Yizhen, Shiliang Liu, Renguo Guan, et al.. (2024). Comparison of resection, ablation, and stereotactic body radiation therapy in treating solitary hepatocellular carcinoma ≤5 cm: a retrospective, multicenter, cohort study. International Journal of Surgery. 111(1). 1535–1540. 4 indexed citations
3.
4.
5.
Zhu, Yujia, Jing Wen, Qiaoqiao Li, et al.. (2023). Toripalimab combined with definitive chemoradiotherapy in locally advanced oesophageal squamous cell carcinoma (EC-CRT-001): a single-arm, phase 2 trial. The Lancet Oncology. 24(4). 371–382. 44 indexed citations
6.
7.
Khan, Muhammad, Sumbal Arooj, Rong Li, et al.. (2020). Tumor Primary Site and Histology Subtypes Role in Radiotherapeutic Management of Brain Metastases. Frontiers in Oncology. 10. 781–781. 17 indexed citations
8.
Li, Qiwen, Bo Qiu, Wanming Hu, et al.. (2020). Plasma Epstein-Barr Virus-Deoxyribonucleic Acid Copy Number Predicts Disease Progression in Stage I–III Pulmonary Lymphoepithelioma-Like Carcinoma. Frontiers in Oncology. 10. 1487–1487. 4 indexed citations
9.
Xu, Anan, Rong Li, Zhong Huang, et al.. (2020). Regulatory coupling between long noncoding RNAs and senescence in irradiated microglia. Journal of Neuroinflammation. 17(1). 321–321. 11 indexed citations
10.
Sha, Zhou, Shiliang Liu, Chuyong Lin, et al.. (2020). TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ. Oncogene. 39(18). 3710–3725. 22 indexed citations
11.
Wang, Baiyao, Jieling Zheng, Rong Li, et al.. (2019). Long noncoding RNA LINC02582 acts downstream of miR-200c to promote radioresistance through CHK1 in breast cancer cells. Cell Death and Disease. 10(10). 764–764. 68 indexed citations
12.
Khan, Muhammad, Jie Lin, Guixiang Liao, et al.. (2019). ALK Inhibitors in the Treatment of ALK Positive NSCLC. Frontiers in Oncology. 8. 557–557. 62 indexed citations
13.
Khan, Muhammad, Jie Lin, Guixiang Liao, et al.. (2018). Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer. Medicine. 97(33). e11936–e11936. 83 indexed citations
14.
Yang, Xin, Zhen‐Yu He, Xiaobo Jiang, et al.. (2017). Development and application of MOSAIQ integration platform based on radiotherapy workflow. Zhonghua fangshe zhongliuxue zazhi. 26(8). 918–923. 2 indexed citations
15.
Zheng, Baomin, Xiaodong Zhu, Mengzhong Liu, et al.. (2017). Randomized, Double-Blind, Placebo-Controlled Trial of Shuanghua Baihe Tablets to Prevent Oral Mucositis in Patients With Nasopharyngeal Cancer Undergoing Chemoradiation Therapy. International Journal of Radiation Oncology*Biology*Physics. 100(2). 418–426. 24 indexed citations
16.
Liao, Zhiwei, Lei Zhao, Muyan Cai, et al.. (2016). P300 promotes migration, invasion and epithelial-mesenchymal transition in a nasopharyngeal carcinoma cell line. Oncology Letters. 13(2). 763–769. 17 indexed citations
17.
Lin, Xiao, Xin Yu, Huixia Feng, et al.. (2016). Pathological Assessment of Rectal Cancer after Neoadjuvant Chemoradiotherapy: Distribution of Residual Cancer Cells and Accuracy of Biopsy. Scientific Reports. 6(1). 34923–34923. 14 indexed citations
18.
Xi, Mian, Mengzhong Liu, Xiaowu Deng, et al.. (2009). Definition of internal target volume and domestric study for hepatocellular carcinoma using four-dimensional CT. Zhonghua fangshe zhongliuxue zazhi. 18(6). 477–481. 1 indexed citations
19.
Li, Qiaoqiao, Yonghong Hu, Mengzhong Liu, et al.. (2009). Results of radiotherapy with concurrent docetaxel and cisplatin in unresectable esophageal carcinoma. Zhonghua fangshe zhongliuxue zazhi. 18(5). 379–382. 1 indexed citations
20.
Chen, Yong, Shaobo Liang, Yan‐Ping Mao, et al.. (2008). A prospective randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma. Clinical Oncology and Cancer Research. 35(14). 785–789. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeremy Setton Breakdown of academic impact, for papers by Shixiu Wu Breakdown of academic impact, for papers by K.K. Ang Breakdown of academic impact, for papers by Peter M. L. Teo Breakdown of academic impact, for papers by Tyler P. Robin Breakdown of academic impact, for papers by Xiaoyu Tu Breakdown of academic impact, for papers by Mei‐Kim Ang Breakdown of academic impact, for papers by Henry Sze Breakdown of academic impact, for papers by Rou Jiang Breakdown of academic impact, for papers by Yi‐Jun Hua
Rankless by CCL
2026